Literature DB >> 28091336

Who are the patients that default tuberculosis treatment? - space matters!

C Nunes1, R Duarte2, A M Veiga1, B Taylor3.   

Abstract

The goals of this article are: (i) to understand how individual characteristics affect the likelihood of patients defaulting their pulmonary tuberculosis (PTB) treatment regimens; (ii) to quantify the predictive capacity of these risk factors; and (iii) to quantify and map spatial variation in the risk of defaulting. We used logistic regression models and generalized additive models with a spatial component to determine the odds of default across continental Portugal. We focused on new PTB cases, diagnosed between 2000 and 2013, and included some individual information (sex, age, residence area, alcohol abuse, intravenous drug use, homelessness, HIV, imprisonment status). We found that the global default rate was 4·88%, higher in individuals with well-known risk profiles (males, immigrants, HIV positive, homeless, prisoners, alcohol and drug users). Of specific epidemiological interest was that our geographical analysis found that Portugal's main urban areas (the two biggest cities) and one tourist region have higher default rates compared to the rest of the country, after adjusting for the previously mentioneded risk factors. The challenge of treatment defaulting, either due to other individual non-measured characteristics, healthcare system failure or patient recalcitrance requires further analysis in the spatio-temporal domain. Our findings suggest the presence of significant within-country variation in the risk of defaulting that cannot be explained by these classical individual risk factors alone. The methods we advocate are simple to implement and could easily be applied to other diseases.

Entities:  

Keywords:  Noncompliance; pulmonary tuberculosis; risk factors; spatial pattern; treatment

Mesh:

Substances:

Year:  2017        PMID: 28091336      PMCID: PMC9507839          DOI: 10.1017/S0950268816003307

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  10 in total

1.  Promoting adherence to tuberculosis treatment.

Authors:  Paul Garner; Helen Smith; Salla Munro; Jimmy Volmink
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

Review 2.  Tuberculosis treatment outcomes in Europe: a systematic review.

Authors:  A Faustini; A J Hall; C A Perucci
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

3.  Nonadherence in tuberculosis treatment: predictors and consequences in New York City.

Authors:  A Pablos-Méndez; C A Knirsch; R G Barr; B H Lerner; T R Frieden
Journal:  Am J Med       Date:  1997-02       Impact factor: 4.965

4.  [Results in pulmonary tuberculosis patients under various treatment program conditions].

Authors:  S Grzybowski; D Enarson
Journal:  Bull Int Union Tuberc       Date:  1978-06

5.  Current status of treatment completion and fatality among tuberculosis patients in Spain.

Authors:  J A Caylà; J A Caminero; R Rey; N Lara; X Vallés; H Galdós-Tangüis
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

6.  Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries.

Authors:  G de Vries; R W Aldridge; J A Cayla; W H Haas; A Sandgren; N A van Hest; I Abubakar
Journal:  Euro Surveill       Date:  2014-03-06

7.  Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco.

Authors:  Kelly E Dooley; Ouafae Lahlou; Iraqi Ghali; Janine Knudsen; My Driss Elmessaoudi; Imad Cherkaoui; Rajae El Aouad
Journal:  BMC Public Health       Date:  2011-02-28       Impact factor: 3.295

Review 8.  Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

Authors:  Rob van Hest; Csaba Ködmön; Suzanne Verver; Connie G M Erkens; Masja Straetemans; Davide Manissero; Gerard de Vries
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

9.  Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study.

Authors:  Tuula Vasankari; Pekka Holmström; Jukka Ollgren; Kari Liippo; Maarit Kokki; Petri Ruutu
Journal:  BMC Public Health       Date:  2007-10-14       Impact factor: 3.295

10.  Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives.

Authors:  Geetika Verma; Ross E G Upshur; Elizabeth Rea; Solomon R Benatar
Journal:  BMC Med Ethics       Date:  2004-03-12       Impact factor: 2.652

  10 in total
  2 in total

1.  [Factors associated with unsuccessful treatment of patients with drug-sensitive tuberculosis in Paraguay].

Authors:  Ivonne Montiel; Edith Alarcón; Sarita Aguirre; Guillermo Sequera; Diana Marín
Journal:  Rev Panam Salud Publica       Date:  2020-08-14

2.  Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review.

Authors:  Debebe Shaweno; Malancha Karmakar; Kefyalew Addis Alene; Romain Ragonnet; Archie Ca Clements; James M Trauer; Justin T Denholm; Emma S McBryde
Journal:  BMC Med       Date:  2018-10-18       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.